Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Functional Regulation of Adipocytes, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Sci Rep. 2017 Aug 4;7(1):7326. doi: 10.1038/s41598-017-06469-5.
CDK5 Regulatory Subunit-Associated Protein 1-like 1 (CDKAL1) was identified as a susceptibility gene for type 2 diabetes and body mass index in genome-wide association studies. Although it was reported that CDKAL1 is a methylthiotransferase essential for tRNA(UUU) and faithful translation of proinsulin generated in pancreatic β cells, the role of CDKAL1 in adipocytes has not been understood well. In this study, we found that CDKAL1 is expressed in adipose tissue and its expression is increased during differentiation. Stable overexpression of CDKAL1, however, inhibited adipocyte differentiation of 3T3-L1 cells, whereas knockdown of CDKAL1 promoted differentiation. CDKAL1 increased protein levels of β-catenin and its active unphosphorylated form in the nucleus, thereby promoting Wnt target gene expression, suggesting that CDKAL1 activated the Wnt/β-catenin pathway-a well-characterized inhibitory regulator of adipocyte differentiation. Mutant experiments show that conserved cysteine residues of Fe-S clusters of CDKAL1 are essential for its anti-adipogenic action. Our results identify CDKAL1 as novel negative regulator of adipocyte differentiation and provide insights into the link between CDKAL1 and metabolic diseases such as type 2 diabetes and obesity.
CDK5 调节亚基相关蛋白 1 样 1(CDKAL1)在全基因组关联研究中被鉴定为 2 型糖尿病和体重指数的易感基因。尽管有报道称 CDKAL1 是一种甲基硫转移酶,对胰腺β细胞中生成的胰岛素原的 tRNA(UUU)和忠实翻译至关重要,但 CDKAL1 在脂肪细胞中的作用尚未得到很好的理解。在这项研究中,我们发现 CDKAL1 在脂肪组织中表达,其表达在分化过程中增加。然而,CDKAL1 的稳定过表达抑制了 3T3-L1 细胞的脂肪细胞分化,而 CDKAL1 的敲低则促进了分化。CDKAL1 增加了细胞核中β-连环蛋白及其活性非磷酸化形式的蛋白水平,从而促进了 Wnt 靶基因的表达,表明 CDKAL1 激活了 Wnt/β-连环蛋白通路——这是一种已被充分研究的脂肪细胞分化抑制因子。突变实验表明,CDKAL1 的 Fe-S 簇保守半胱氨酸残基对于其抗脂肪生成作用是必需的。我们的研究结果确定了 CDKAL1 是脂肪细胞分化的新型负调控因子,并为 CDKAL1 与 2 型糖尿病和肥胖等代谢疾病之间的联系提供了新的认识。